Global Colistin Sulphate Market 2016 - Xellia Pharmaceuticals, Meiji Seika, Shenghua Biok, Hebei Shengxue Dacheng, Tianjin Xinxing, Apeloa Kangyu, Shandong Lukang, Fujian Hequan

This report provides detailed analysis of worldwide markets for Colistin Sulphate from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Colistin Sulphate market and further lays out an analysis of the factors influencing the supply/demand for Colistin Sulphate, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Request for sample report at http://www.fiormarkets.com/report-detail/1111/request-sample

Colistin (polymyxin E) is a polymyxin antibiotic produced by certain strains of Paenibacillus polymyxa var. colistinus. Colistin is a mixture of cyclic polypeptides colistin A and B. Colistin is effective against most Gram-negative bacilli and is used as a polypeptide antibiotic. There are two forms of colistin available commercially: colistin sulfate and colistimethate sodium (colistin methanesulfonate sodium, colistin sulfomethate sodium). Colistin sulfate is cationic; colistimethate sodium is anionic. Colistin sulfate is stable, but colistimethate sodium is readily hydrolysed to a variety of methanesulfonated derivatives. Colistin sulfate and colistimethate sodium are eliminated from the body by different routes. With respect to Pseudomonas aeruginosa, colistimethate is the inactive prodrug of colistin. The two drugs are not interchangeable. Colistin sulfate may be used to treat intestinal infections, or to suppress colonic flora. Colistin sulfate is also used as topical creams, powders, and otic solutions.

Access full report at http://www.fiormarkets.com/report/global-colistin-sulphate-market-outlook-2016-2021-1111.html

Global Colistin Sulphate Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Colistin Sulphate market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Colistin Sulphate market areXellia Pharmaceuticals (Denmark), Meiji Seika (Japan), Shenghua Biok (China), Hebei Shengxue Dacheng (China), Tianjin Xinxing (China), Apeloa Kangyu (China), Shandong Lukang (China), Fujian Hequan (China).

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Colistin Sulphate industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.